LEADER 02992nam 2200577Ia 450 001 9910781151803321 005 20230725045052.0 010 $a6612601019 010 $a1-282-60101-6 010 $a9786612601019 010 $a1-60750-525-8 035 $a(CKB)2550000000012857 035 $a(EBL)501461 035 $a(OCoLC)620959900 035 $a(SSID)ssj0000430049 035 $a(PQKBManifestationID)11271462 035 $a(PQKBTitleCode)TC0000430049 035 $a(PQKBWorkID)10468012 035 $a(PQKB)11268597 035 $a(MiAaPQ)EBC501461 035 $a(Au-PeEL)EBL501461 035 $a(CaPaEBR)ebr10375709 035 $a(CaONFJC)MIL260101 035 $a(EXLCZ)992550000000012857 100 $a20100401d2010 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTravel medicine$b[electronic resource] $eknowledge, attitude, practice and immunisation /$fAnna Helena Elvire Roukens 210 $aAmsterdam $cIOS Press$dc2010 215 $a1 online resource (200 p.) 300 $aDescription based upon print version of record. 311 $a1-60750-483-9 327 $aTitle page; Contents; Chapter outline; General introduction; Performance of self-diagnosis and standby treatment of malaria in international oilfield service employees in the field; Health preparations and travel-related morbidity of kidney transplant recipients travelling to developing countries; Symptoms of infectious diseases in travelers with diabetes: a prospective study with matched controls; Yellow fever vaccination of the elderly: the humoral immune response lagging behind; Intradermal Hepatitis B vaccination in non-responders after topical application of imiquimod (Aldaraź) 327 $aIntradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomised controlled non-inferiority trial Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy; Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a Purified Chicken Embryo Cell Vaccine (PCECV) is immunogenic and safe in adults; Summary and discussion; Nederlandse samenvatting; Abbreviations; Publications; Curriculum vitae 330 $aAddresses the subject of travel medicine and improving protection, with regard particularly to the areas of epidemiology and prevention, morbidity and mortality, adherence to precautions, immunological responsivity and the availability of preventive measures. 606 $aTravelers$xDiseases 606 $aTravel$xHealth aspects 615 0$aTravelers$xDiseases. 615 0$aTravel$xHealth aspects. 676 $a616.9802 700 $aRoukens$b Anna Helena Elvire$01515284 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910781151803321 996 $aTravel medicine$93750937 997 $aUNINA